Search SciPol

Brought to you by
November
7

Meeting: ECHA, Nanomaterials Expert Group

  • Nanotechnology

ECHA announced the next meeting of the Nanomaterials Expert Group (NMEG). The NMEG supports the implementation of the Nanomaterials 2016-2018 Workplan of ECHA, and provides informal advice on scientific and technical issues regarding the implementation of regulations of REACH, CLP, and BPR for nanomaterials. 

October
25

Meeting: 2017 NIH Regional Seminar – Program Funding and Grants Administration

  • Agency
  • Genetics/Genomics
  • Neuroscience

The National Institutes of Health (NIH)'s Regional Seminar serves the NIH mission of providing education and training for the next generation of biomedical and behavioral scientists. The seminar and optional workshops are appropriate for those who are new to working with the NIH grants process – administrators, new and early stage investigators, researchers, graduate students, etc.

October
17

Meeting: HHS Secretary’s Advisory Committee on Human Research Protections

  • Agency
  • Genetics/Genomics
  • Neuroscience

The Secretary’s Advisory Committee on Human Research Protections (SACHRP) shall provide expert advice and recommendations to the Secretary, through the Assistant Secretary for Health (ASH), on issues and topics pertaining to or associated with the protection of human research subjects. The...

September
28

Meeting: NIH Recombinant DNA Advisory Committee

  • Agency
  • Genetics/Genomics

The National Institutes of Health's Recombinant DNA Advisory Committee is a federal advisory committee that provides recommendations to the NIH Director related to basic and clinical research involving recombinant or synthetic nucleic acid molecules.

September
11

Meeting: NIH National Advisory Council for Human Genome Research

  • Agency
  • Genetics/Genomics

The National Advisory Council for Human Genome Research (NACHGR) within the National Institutes of Health (NIH) is holding an open meeting to discuss matters of program relevance. The NACHGR advises the Department of Health and Human Services, the NIH, and the...

August
10

Meeting: NAS, Occupational Exposure to Respirable Coal-Mine Dust – 5th Meeting

  • Nanotechnology

NAS announces a fifth public meeting on “Occupational Exposure to Respirable Coal-Mine Dust” to assess monitoring and sampling approaches for informing underground coal mine operators’ decision-making regarding the control of respirable coal mine dust and mine worker exposure. 

July
31

Meeting: DOE 2017 Joint Nanoscience and Neutron Scattering User Meeting

  • Other
  • Nanotechnology

The Executive Committees for the Center for Nanophase Materials Sciences (CNMS) and SNS/HFIR User Groups are pleased to announce the 2017 Joint Nanoscience and Neutron Scattering User Meeting supported by the U.S. Department of Energy's Office of Science

July
31

Workshop: NASEM Neurocognitive and Psychosocial Impacts of Violence

  • Agency
  • Neuroscience

A planning committee for the National Academies's Forum on Global Violence Prevention will hold a two-day public workshop designed to illuminate the current state of the science surrounding the impacts of exposure to violence and trauma on both neurocognitive and psychosocial outcomes.

July
25

Meeting: HHS Secretary’s Advisory Committee on Human Research Protections

  • Agency
  • Genetics/Genomics
  • Neuroscience

The Secretary’s Advisory Committee on Human Research Protections (SACHRP) shall provide expert advice and recommendations to the Secretary, through the Assistant Secretary for Health (ASH), on issues and topics pertaining to or associated with the protection of human research subjects. The...

June
30

Meeting: NCATS Advocacy Day: "Partnering with Patients for Smarter Science"

  • Government
  • Agency
  • Genetics/Genomics
  • Neuroscience

The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health will hold its inaugural NCATS Advocacy Day ― Partnering with Patients for Smarter Science. The purpose of the event is to inform patients and their advocates about NCATS, including its philosophy and programmatic approaches; identify patient needs; and collectively discuss ways for improved patient inclusion in NCATS’ translational science activities.

Pages